Lupin Ltd has introduced Ipratropium Bromide nasal spray in the US, available in 0.03% and 0.06% strengths. These sprays, ...

Mumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in ...

Ipratropium bromide nasal solution (Nasal Spray) 0.03% is indicated for the symptomatic relief of rhinorrhea associated with ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

Global Animal Health Market is expected to grow at a rate of 8-9% by 2029. Growing awareness of animal health products, ...

Lupin introduces ipratropium bromide nasal solution, 0.03% & 0.06% in US markets: Our Bureau, Mumbai Friday, July 4, 2025, 17:30 Hrs [IST] Global pharma major Lupin Limited (Lupin ...

Lupin announced the launch of Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in the United States. Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06% are ...

Lupin has announced the launch of Ipratropium Bromide Nasal Solution (nasal spray) in two strengths in the United States.

The Business Research Company The Business Research Company's Asperger Syndrome Market 2025: Strategic Insights for Business Growth, Expans ...

Lupin launches Ipratropium Bromide nasal spray in US, bioequivalent to Atrovent. The product addresses rhinitis and targets a $63 million market opportunity.

The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and ...